Trulieve Cannabis Corp.

TRLV NYSE SEC CIK 1754195
Follow Trulieve Cannabis Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $230.2M −20.1% vs same quarter last year
Net income $774K +102.7% vs same quarter last year
EPS, diluted $0.00 +100% vs same quarter last year
Operating cash flow $74.4M −2.6% vs same quarter last year
Revenue by quarter
$301.1M
$297.8M
$302.1M
$288.2M
$293.1M
$286.8M
$271M
$230.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$1B−$500M$0$500M$1B$1.5BFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1.2B−$116.4M
FY24$1.2B−$155.1M
FY23$1.1B−$526.8M
FY22$1.2B−$246.1M
FY21$931.9M$18M
FY20$521.5M$63M
FY19$252.8M$53.1M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%0%50%100%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2560.2%12.1%−9.9%
FY2460.3%8.2%−13.1%
FY2352.1%−19.6%−46.7%
FY2256.6%4.1%−20.2%
FY2160.8%21.9%1.9%
FY2074.1%41.9%12.1%
FY1975.9%44.8%21%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$400M−$200M$0$200M$400MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$228.6M
FY24$148.9M
FY23$161.6M
FY22−$141.7M
FY21−$263M
FY20−$298K
FY19−$52.8M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Trulieve Cannabis Corp.
  • Healthcare median
−100%−50%0%50%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearTrulieve Cannabis Corp.Healthcare median
FY25−9.9%−30.6%
FY24−13.1%−47%
FY23−46.7%−58%
FY22−20.2%−80.4%
FY211.9%−71.9%
FY2012.1%−62.2%
FY1921%−46.3%
FY18-−49.6%